case_images: PMC11694284_01
case_images: Scalp plaques before initiation of deucravacitinib and 6 months after initiation of deucravacitinib. (a) Left frontal scalp plaque pre-deucravacitinib. (b) Left frontal scalp plaque post-deucravacitinib. (c) Right frontal scalp plaque pre-deucravacitinib. (d) Right frontal scalp plaque post-deucravacitinib. (e) Left posterior scalp plaque pre-deucravacitinib. (f) Left posterior scalp plaque post-deucravacitinib.
case_images: 10.1177_2050313X241304891-fig1.jpg
case_images: PMC11694284_01_10.1177_2050313X241304891-fig1.jpg
case_images: fig1-2050313X241304891
case_images: Physical examination revealed three distinct areas of scarring alopecia on her left frontal (Figure 1(a)), right frontal (Figure 1(c)), and left posterior scalp (Figure 1(e)) with erythema and scale. Six months post-deucravacitinib initiation, the patient demonstrated significant hair regrowth and a reduction in plaque size (Figure 1(b), (d), (f)). The apparent erythema in Figure 1(f) was not noticed clinically, and we feel that this was an artifact of the photograph.